No paralogue variants have been mapped to residue 1386 for CACNA1C.
CACNA1C | SFQALPYVALLIVMLFFIYAVIGMQVFGKI>A<LND---TTE-----INRNNNFQTFPQAVLL | 1408 |
CACNA1A | SFKALPYVCLLIAMLFFIYAIIGMQVFGNI>G<IDVEDEDSDEDEFQITEHNNFRTFFQALML | 1748 |
CACNA1B | SFKALPYVCLLIAMLFFIYAIIGMQVFGNI>A<LDD---DTS-----INRHNNFRTFLQALML | 1648 |
CACNA1D | SFQALPYVALLIAMLFFIYAVIGMQMFGKV>A<MRD---NNQ-----INRNNNFQTFPQAVLL | 1418 |
CACNA1E | SFKALPYVCLLIAMLFFIYAIIGMQVFGNI>K<LDE---ESH-----INRHNNFRSFFGSLML | 1655 |
CACNA1F | SFQALPYVALLIAMIFFIYAVIGMQMFGKV>A<LQD---GTQ-----INRNNNFQTFPQAVLL | 1375 |
CACNA1G | ALPQVGNLGLLFMLLFFIFAALGVELFGDL>E<CDET---HP--CEGLGRHATFRNFGMAFLT | 1794 |
CACNA1H | ALPQVGNLGLLFMLLFFIYAALGVELFGRL>E<CSED---NP--CEGLSRHATFSNFGMAFLT | 1800 |
CACNA1I | ALPQVGNLGLLFMLLFFIYAALGVELFGKL>V<CNDE---NP--CEGMSRHATFENFGMAFLT | 1670 |
CACNA1S | SFQALPYVALLIVMLFFIYAVIGMQMFGKI>A<LVD---GTQ-----INRNNNFQTFPQAVLL | 1315 |
SCN10A | SLPALFNIGLLLFLVMFIYSIFGMSSFPHV>R<W-----EAG-----IDDMFNFQTFANSMLC | 1653 |
SCN11A | SLPSLFNIGLLLFLIMFIYAILGMNWFSKV>N<P-----ESG-----IDDIFNFKTFASSMLC | 1543 |
SCN1A | SLPALFNIGLLLFLVMFIYAIFGMSNFAYV>K<R-----EVG-----IDDMFNFETFGNSMIC | 1716 |
SCN2A | SLPALFNIGLLLFLVMFIYAIFGMSNFAYV>K<R-----EVG-----IDDMFNFETFGNSMIC | 1706 |
SCN3A | SLPALFNIGLLLFLVMFIYAIFGMSNFAYV>K<K-----EAG-----IDDMFNFETFGNSMIC | 1701 |
SCN4A | SLPALFNIGLLLFLVMFIYSIFGMSNFAYV>K<K-----ESG-----IDDMFNFETFGNSIIC | 1528 |
SCN5A | SLPALFNIGLLLFLVMFIYSIFGMANFAYV>K<W-----EAG-----IDDMFNFQTFANSMLC | 1703 |
SCN7A | SLPALLNIILLIFLVMFIYAVFGMYNFAYV>K<K-----EAG-----INDVSNFETFGNSMLC | 1426 |
SCN8A | SLPALFNIGLLLFLVMFIFSIFGMSNFAYV>K<H-----EAG-----IDDMFNFETFGNSMIC | 1697 |
SCN9A | SLPALFNIGLLLFLVMFIYAIFGMSNFAYV>K<K-----EDG-----INDMFNFETFGNSMIC | 1679 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.A1386S | c.4156G>T | Putative Benign | rs370247532 | SIFT: tolerated Polyphen: probably damaging |